Table 5 Univariate Cox regression analysis for locoregional failure and distant failure
Locoregional failure | Distant failure | |||||||
|---|---|---|---|---|---|---|---|---|
Event | HR | 95% CI | P-value | Event | HR | 95% CI | P-value | |
Gender | ||||||||
Male (n = 101) | 16 | 1.00 | 20 | 1.00 | ||||
Female (n = 27) | 5 | 1.11 | 0.41-3.04 | 0.83 | 2 | 0.36 | 0.08-1.53 | 0.16 |
WHO Classification | ||||||||
Type I (n = 6) | 1 | 1.00 | 1 | 1.00 | ||||
Type II (n = 43) | 8 | 0.98 | 0.12-7.82 | 0.98 | 6 | 0.75 | 0.09-6.21 | 0.79 |
Type III (n = 79) | 12 | 0.83 | 0.11-6.39 | 0.86 | 15 | 1.05 | 0.14-7.94 | 0.96 |
cT | ||||||||
T1-2 (n = 75) | 9 | 1.00 | 10 | 1.00 | ||||
T3-4 (n = 53) | 12 | 2.11 | 0.89-5.02 | 0.09 | 12 | 1.90 | 0.82-4.39 | 0.14 |
cN | ||||||||
N0-1 (n = 34) | 5 | 1.00 | 3 | 1.00 | ||||
N2-3 (n = 94) | 16 | 1.20 | 0.44-3.29 | 0.72 | 19 | 2.43 | 0.72-8.24 | 0.15 |
Stage | ||||||||
IIB/III (n = 83) | 9 | 1.00 | 10 | 1.00 | ||||
IVA/IVB (n = 45) | 12 | 2.84 | 1.19-6.77 | 0.02 | 12 | 2.62 | 1.13-6.08 | 0.02 |
Treatment | ||||||||
CCRT group (n = 90) | 12 | 1.00 | 14 | 1.00 | ||||
NACT group (n = 38) | 9 | 1.75 | 0.74-4.16 | 0.20 | 8 | 1.29 | 0.54-3.08 | 0.56 |